ESMO Conference Platform

ESMO 2018 Congress

Final Programme PDF Advanced Search

08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00

Hall A1 - Room 15

10:45(2h)ESMO Clinical Practice Guidelines 1
14:30(2h)ESMO Clinical Practice Guidelines 2
18:30(1h 30m)ESMO COLLOQUIUM - Acute Myeloid Leukemia – Focus on FLT3-ITD mutation
16:45(1h)Gene expression signatures should be used in luminal node negative breast cancer
09:30(1h)Identification of ultra-rare, life-saving molecular subtypes of cancer – NGS for everyone, some or none?
08:00(1h)Should oligosymtomatic brain metastasis patients without oncogene addiction receive upfront systemic therapy?

Hall A1 - Room 16

18:30(1h 30m)ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?
13:00(1h 30m)Industry satellite symposium 31
11:00(1h 30m)Integrating radiation in immunotherapy schemes
09:30(1h)Integration of immunotherapy with disease entities
15:00(1h)Management of toxicities of immunotherapy
16:30(1h)Molecular tumour boards in the practice of precision oncology
08:00(1h)The right time for discontinuing immunotherapy

Hall A1 - Room 17

08:15(45m)How do we manipulate the tumour microenvironment for immunotherapy?
11:10(1h 30m)Proffered paper session - Gastrointestinal tumours, non colorectal
09:15(1h 40m)Proffered paper session - Non-metastatic NSCLC and other thoracic malignancies
14:45(1h 30m)Tumour heterogeneity in gynaecological cancers

Hall A2 - Room 18

14:45(1h 30m)Combination strategies of immunotherapy in breast cancer
09:15(1h 30m)Precision cancer medicine in metastatic colorectal cancer
16:30(1h 40m)Presidential Symposium 2
11:00(1h 30m)Safe de-escalation of therapy in the management of early breast cancer

Hall B3 - Room 20

09:30(1h 05m)Dissecting mediastinal grey zone lymphomas
13:00(1h 30m)Industry satellite symposium 32
18:30(1h 30m)Industry satellite symposium 40
08:00(1h)Personalised breast cancer medicine: Should all patients have whole genome sequencing?
11:10(1h 05m)Pre-op/neoadjuvant treatments in sarcomas: “Think twice before you open it”
14:45(1h 30m)Proffered paper session - Supportive and palliative care

Hall B3 - Room 21

08:00(1h)Challenging germ cell tumour patients
09:15(1h 30m)Opportunities in clinic trial design in the era of genomics and immuno-oncology
16:30(1h 15m)Poster Discussion session - Haematological malignancies
11:15(1h)Poster Discussion session - Translational research 2
14:45(1h 30m)Sarcomas as a key foundation for molecular-targeted basket trials

Hall B3 - Room 22

14:45(1h 30m)Emerging therapies in neuroendocrine and endocrine malignancies
13:00(1h 30m)ESMO COLLOQUIUM - Immune check point inhibitors: Are we ready for combination?
11:00(1h 30m)Proffered paper session - Developmental therapeutics
08:00(1h)Small bowel adenocarcinomas
09:30(1h)Using population data evidence to support policy decisions in cancer

Hall B3 - Room 23

09:30(1h)Challenges in the treatment of early stage ovarian cancer
13:00(1h 30m)Industry satellite symposium - EONS 5
11:10(1h 05m)Multidisciplinary perspectives in stage I-II NSCLC management
08:00(1h)Multiscale tumor heterogeneity: Clinical implications
15:00(1h)Precision medicine in daily practice: Recommendations from the ESMO Precision Medicine Working Group

Hall B4 - Room 19

13:00(1h 30m)Industry satellite symposium 34
18:30(1h 30m)Industry satellite symposium 41
11:00(1h 30m)Proffered paper session - Haematological malignancies
08:00(1h)Special session: Summary of the ESMO-ESGO consensus conference on ovarian cancer

ICM - Room 1

13:00(1h 30m)Industry satellite symposium 28
18:30(1h 30m)Industry satellite symposium 35
09:15(1h 15m)Poster Discussion session - Breast cancer, metastatic
14:45(1h 15m)Poster Discussion session - Non-metastatic NSCLC and other thoracic malignancies
11:00(1h 30m)The critical need of a multidisciplinary approach for the treatment of prostate cancer
16:30(1h 30m)Unresolved questions in melanoma

ICM - Room 13

13:00(1h 30m)Industry satellite symposium 30
18:30(1h 30m)Industry satellite symposium 37
09:15(1h 30m)Modern tools to optimise therapy for patients with head and neck cancer
11:00(1h 30m)Novel therapies for brain tumors
16:45(1h)Poster Discussion session - NSCLC, metastatic 2
14:45(1h 30m)Revisiting systemic therapy in HNSCC in the era of immunotherapy

ICM - Room 14a

14:45(1h 30m)Are there enough cancer services and oncologists in your country?
08:00(1h)Follicular and other indolent lymphomas
16:30(2h)Improving research, education and clinical practice in oncology and palliative care - 5th ESMO Designated Centres Community Session and Awards
09:10(1h 35m)Practicing oncologists and rare tumours
11:00(45m)YO Brunch 2: Breaking bad news: How to deal with end-of-life discussions

ICM - Room 14b

13:00(1h 30m)Industry satellite symposium 29
18:30(1h 30m)Industry satellite symposium 36
15:00(1h 05m)Locally advanced pancreatic cancer
11:00(1h 30m)Optimal antineoplastic therapy and supportive care of elderly cancer patients
16:45(1h)Poster Discussion session - Gastrointestinal tumours, colorectal 2
09:15(1h 15m)Poster Discussion session - Genitourinary tumours, prostate

ICM - Room 5

18:00(1h 30m)Snake oil sold as science: How to protect patients from Pseudoscience
12:30(1h 30m)The cancer drugs we need: Incentivising innovation in cancer

Hall B4 - Room 24

12:00(1h)EONS Poster display
16:30(1h 30m)Improving communication in cancer nursing
13:00(1h 30m)Industry satellite symposium - EONS 6
18:30(1h 30m)Industry satellite symposium - EONS 7
08:00(1h)Self-care for young cancer nurses
11:00(1h)Symptom management
09:15(1h 30m)Symptom management: Clinical aspects and implementation
14:45(1h 30m)The essential elements of safety standards for systemic cancer therapies

ICM - Room 14c

14:30(3h)YO Masterclass: From genetic data to clinical trial design: Joint session EACR and ESMO YOC

Hall A3 - Poster Area Networking Hub

12:45(1h)Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology